Evidence map›Paper›PMID 42384395›Full record

ArticleThe Journal of physiology2026

Ca

Miguel Martin-Aragon Baudel, Hannah Voorhees, Arsalan U Syed, Maryann K Ferrara, Mary Horne, Johannes W Hell, Luis F Santana, Rose E Dixon, Madeline Nieves-Cintron, Manuel F Navedo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miguel Martin-Aragon BaudelDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID https://orcid.org/0000-0001-9399-4013
Hannah VoorheesDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID https://orcid.org/0009-0007-1289-8267
Arsalan U SyedDepartment of Pharmacology, University of California Davis, Davis, CA, USA.
Maryann K FerraraDepartment of Pharmacology, University of California Davis, Davis, CA, USA.
Mary HorneDepartment of Pharmacology, University of California Davis, Davis, CA, USA.
Johannes W HellDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID https://orcid.org/0000-0001-7960-7531
Luis F SantanaDepartment of Physiology & Membrane Biology, University of California Davis, Davis, CA, USA.ORCID https://orcid.org/0000-0002-4297-8029
Rose E DixonDepartment of Physiology & Membrane Biology, University of California Davis, Davis, CA, USA.ORCID https://orcid.org/0000-0003-0655-690X
Madeline Nieves-CintronDepartment of Pharmacology, University of California Davis, Davis, CA, USA.
Manuel F NavedoDepartment of Pharmacology, University of California Davis, Davis, CA, USA.ORCID https://orcid.org/0000-0001-6864-6594

Funding

Coupling of Vascular Cav1.2 Channels In Health & DiseaseR01HL121059 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2015 to 2024
$4.5M
Role of a-actinin in Cav1.2 FunctionR01AG055357 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2016 to 2026
$4.0M
Molecular choreography of CaV1.2 channels in the aging myocardiumR01AG063796 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Rose Ellen Dixon · 2019 to 2026
$3.1M
Lipid regulation of Cardiac Excitation-Contraction couplingR01HL159304 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DIXON, ROSE ELLEN · 2022 to 2025
$2.4M
Postsynaptic Signaling by Norepinephrine and cAMPR01NS123050 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JOHANNES W HELL · 2022 to 2026
$2.3M
Training Program in PharmacologyT32GM144303 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, JOHANNES W HELL · 2022 to 2026
$2.1M
Mechanisms of VSM dysfunction in diabetes and HFpEFR01HL171014 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Manuel F Navedo, Madeline Nieves-Cintron · 2024 to 2026
$2.0M
Pressure Regulation of Vascular CaV1.2 ChannelsR01HL180444 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Manuel F Navedo · 2025 to 2026
$1.5M
AHA Career Development Award 26CDA1609534NHLBI NIH HHS R01 HL121059NHLBI NIH HHS R01 HL159304NHLBI NIH HHS R01 HL171014NHLBI NIH HHS R01 HL180444NIA NIH HHS R01 AG055357NIA NIH HHS R01 AG063796NIGMS NIH HHS T32 GM144303NIH HHS R01AG055357NIH HHS R01AG063796NIH HHS R01HL121059NIH HHS R01HL159304NIH HHS R01HL171014NIH HHS R01HL180444NIH HHS R01NS123050NIH HHS T32GM144303NINDS NIH HHS R01 NS123050
6 · The paper itself

Abstract

L-type Ca

Indexed as

ArteriesCalcium Channels, L-TypeMyocytes, Smooth MuscleAngiotensin IIAnimalsCells, CulturedHyperglycemiaMaleMiceMice, Inbred C57BLMicrotubulesAngiotensin IICACNA1C protein, mouseCalcium Channels, L-TypeL-type calcium channel alpha(1C)calcium channelsclusteringcontractilitytrafficking

Identifiers

PMID42384395
PMCPMC13423133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.